Elevated Expression of RGS2 May Underlie Reduced Olfaction in COVID-19 Patients
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
Anosmia is common in COVID-19 patients, lasting for weeks or months following recovery. The biological mechanism underlying olfactory deficiency in COVID-19 does not involve direct damage to nasal olfactory neurons, which do not express the proteins required for SARS-CoV-2 infection. A recent study suggested that anosmia results from downregulation of olfactory receptors. We hypothesized that anosmia in COVID-19 may also reflect SARS-CoV-2 infection-driven elevated expression of regulator of G protein signaling 2 (RGS2), a key regulator of odorant receptors, thereby silencing their signaling. To test our hypothesis, we analyzed gene expression of nasopharyngeal swabs from SARS-CoV-2 positive patients and non-infected controls (two published RNA-sequencing datasets, 580 individuals). Our analysis found upregulated RGS2 expression in SARS-CoV-2 positive patients (FC = 14.5, Padj = 1.69 × 10−5 and FC = 2.4; Padj = 0.001, per dataset). Additionally, RGS2 expression was strongly correlated with PTGS2, IL1B, CXCL8, NAMPT and other inflammation markers with substantial upregulation in early infection. These observations suggest that upregulated expression of RGS2 may underlie anosmia in COVID-19 patients. As a regulator of numerous G-protein coupled receptors, RGS2 may drive further neurological symptoms of COVID-19. Studies are required for clarifying the cellular mechanisms by which SARS-CoV-2 infection drives the upregulation of RGS2 and other genes implicated in inflammation. Insights on these pathway(s) may assist in understanding anosmia and additional neurological symptoms reported in COVID-19 patients.
Article activity feed
-
-
SciScore for 10.1101/2022.05.12.22274991: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics not detected. Sex as a biological variable not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Table 2: Resources
Software and Algorithms Sentences Resources We analyzed RNA-sequencing data from two NCBI Gene Expression Omnibus (GEO) database: GSE163151 (11) and GSE152075 (12) to comparing the expression of RGS2 in SARS-CoV-2 positive and negative nasopharyngeal epithelial cells. Gene Expression Omnibussuggested: (Gene Expression Omnibus (GEO, RRID:SCR_005012)For this analysis we applied a generalized linear model under the standard DESeq2 method (13). DESeq2suggested: (DESeq, RRID:SCR_000154)Figures were plotted using GraphPad Prism version 9.3.1 for Windows, … SciScore for 10.1101/2022.05.12.22274991: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics not detected. Sex as a biological variable not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Table 2: Resources
Software and Algorithms Sentences Resources We analyzed RNA-sequencing data from two NCBI Gene Expression Omnibus (GEO) database: GSE163151 (11) and GSE152075 (12) to comparing the expression of RGS2 in SARS-CoV-2 positive and negative nasopharyngeal epithelial cells. Gene Expression Omnibussuggested: (Gene Expression Omnibus (GEO, RRID:SCR_005012)For this analysis we applied a generalized linear model under the standard DESeq2 method (13). DESeq2suggested: (DESeq, RRID:SCR_000154)Figures were plotted using GraphPad Prism version 9.3.1 for Windows, GraphPad Software, La Jolla, CA, USA. GraphPad Prismsuggested: (GraphPad Prism, RRID:SCR_002798)GraphPadsuggested: (GraphPad Prism, RRID:SCR_002798)Results from OddPub: Thank you for sharing your data.
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
Results from scite Reference Check: We found no unreliable references.
-